Profil bibliographique

Yoshio Saburi

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

115Publications signalées

4045Citations signalées

1Affiliations récentes

Institutions déclarées

Domaines associés

T-cell and Retrovirus StudiesChronic Lymphocytic Leukemia ResearchVector-Borne Animal DiseasesChronic Myeloid Leukemia TreatmentsLymphoma Diagnosis and Treatment

Publications récentes

Accès ouvert 2026 articleOpenAlex

Activated Memory Cytotoxic T-Lymphocytes and T-Cell Receptor Vβ Clonality Predict Treatment-Free Remission After Tyrosine Kinase Inhibitor Discontinuation in Chronic-Phase Chronic Myeloid Leukemia: A 1-Year Prospective Immuno-Monitoring Study

Tatsuro Jo, Yoshio Saburi, Taro Masunari, Kazuhiro Noguchi et autres

3 citationsInternational Journal of Molecular Sciences

Accès ouvert 2026 articleOpenAlex

Five-year interim analysis of J-SKI: an observational study of TKI discontinuation in patients with CML in Japan

Naoto Takahashi, Shinya Kimura, Eri Matsuki, Takaaki Ono et autres

3 citationsInternational Journal of Hematology

2025 conference-abstractOpenAlex

Five-year interim analysis of multi-institutional collaborative study for estimating the persistence of treatment free remission in chronic myeloid leukemia after stopping tyrosine kinase inhibitor in Japan: J-SKI

Naoto Takahashi, Shinya Kimura, Eri Matsuki, Taka-aki Ono et autres

1 citationBlood

Accès ouvert 2024 conference-abstractOpenAlex

Impact of Cooperating Myeloid Gene Mutations on Disease Progression and Survival in Japanese MPN Patients: A Multicenter Study

Kotaro Shide, Masami Takeuchi, Kosei Matsue, Takuro Kameda et autres

0 citationsBlood

2024 conference-abstractOpenAlex

An observational study on the relationship between tyrosine kinase inhibitor treatment-free remission and cytotoxic T-lymphocytes in patients with chronic phase chronic myeloid leukemia.

Tatsuro Jo, Yoshio Saburi, Taro Masunari, Toru Kiguchi et autres

0 citationsJournal of Clinical Oncology

2024 articleOpenAlex

Characteristics of chronic lymphocytic leukemia in Japan: Comprehensive analysis of the CLLRSG-01 study

Jun Takizawa, Ritsuro Suzuki, Koji Izutsu, Toru Kiguchi et autres

5 citationsInternational Journal of Hematology

Accès ouvert 2022 articleOpenAlex

Successful treatment with tirabrutinib for relapsed Bing-Neel syndrome following high-dose methotrexate and craniospinal irradiation

Masuho Saburi, Masanori Sakata, Kazuki Okuhiro, Katsuya Kawano et autres

8 citationsJournal of the Japan Society of the Reticuloendothelial System

2021 articleOpenAlex

Successful treatment with tirabrutinib for relapsed lymphoplasmacytic lymphoma complicated by Bing–Neel syndrome

Masuho Saburi, Yoshio Saburi, Katsuya Kawano, Ryuichi Sato et autres

13 citationsInternational Journal of Hematology

2021 articleOpenAlex

Fungal biomarker monitoring and CT scans for early detection of invasive fungal disease in neutropenic hematological patients

Shun‐ichi Kimura, Yoshinobu Kanda, Tatsuo Oyake, Hiroki Yamaguchi et autres

4 citationsJournal of Infection

Accès ouvert 2020 articleOpenAlex

Efficacy and safety of micafungin in empiric and D-index-guided early antifungal therapy for febrile neutropenia; A subgroup analysis of the CEDMIC trial

Shun‐ichi Kimura, Yoshinobu Kanda, Masaki Iino, Takahiro Fukuda et autres

7 citationsInternational Journal of Infectious Diseases

2020 articleOpenAlex

D-Index–Guided Early Antifungal Therapy Versus Empiric Antifungal Therapy for Persistent Febrile Neutropenia: A Randomized Controlled Noninferiority Trial

Yoshinobu Kanda, Shun‐ichi Kimura, Masaki Iino, Takahiro Fukuda et autres

30 citationsJournal of Clinical Oncology

2019 articleOpenAlex

D-index-guided early antifungal therapy for persistent FN in patients with hematological malignancies (CEDMIC trial)

Emiko Sakaida, Yoshinobu Kanda, Shun‐ichi Kimura, Masaki Iino et autres

0 citationsAnnals of Oncology

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.